Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C103303 |
alitretinoin |
alitretinoin results in decreased expression of CCR7 protein | decreases expression | 17475839
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of CCR7 protein | increases expression | 17475839
|
D001554 |
Benzene |
Benzene results in decreased expression of CCR7 | decreases expression | 15935813
|
D001554 |
Benzene |
Benzene results in decreased expression of CCR7 mRNA | decreases expression | 12928149
|
D001554 |
Benzene |
TP53 protein promotes the reaction [Benzene results in decreased expression of CCR7] | decreases expression|increases reaction | 15935813
|
D001554 |
Benzene |
TRP53 protein affects the reaction [Benzene results in decreased expression of CCR7 mRNA] | affects reaction|decreases expression | 12928149
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CCR7 mRNA | increases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CCR7 mRNA | increases expression | 20106945
|
D004137 |
Dinitrochlorobenzene |
Dinitrochlorobenzene results in increased expression of CCR7 protein | increases expression | 15737199
|
D004137 |
Dinitrochlorobenzene |
Dinitrochlorobenzene results in increased expression of CCR7 mRNA | increases expression | 19159591
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of CCR7 mRNA | decreases expression | 15885639 12538720
|
C022838 |
nickel chloride |
nickel chloride results in increased expression of CCR7 protein | increases expression | 15737199
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of CCR7 mRNA | increases expression | 16780908
|
D015232 |
Dinoprostone |
Dinoprostone results in increased expression of CCR7 mRNA | increases expression | 16303787
|
D015232 |
Dinoprostone |
Dinoprostone results in increased expression of CCR7 protein | increases expression | 16303787
|
C089730 |
rosiglitazone |
rosiglitazone results in decreased expression of CCR7 protein | decreases expression | 17475839
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of CCR7 mRNA | decreases expression | 12676792
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CCR7 mRNA | increases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 15322242 11752688 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
4.42 | 11954676 16100012 12718980 19131640 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.26 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.26 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.71 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Dinoprostone |
5.13 | 17942926 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.87 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.08 | 17306315 16712894 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.87 | 19621015 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.45 | 17661222 11369114 14761424 |
MESH:D001014 |
Aortic Aneurysm |
|
Dinoprostone |
5.73 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
12.46 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Dinoprostone |
12.46 | 10388637 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
MESH:D001477 |
Bartter Syndrome |
|
Dinoprostone |
5.88 | 15976003 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.15 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
5.40 | 16183116 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.01 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
2.01 | 17162533 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.01 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.01 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
1.99 | 17306315 16507464 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.70 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.70 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.81 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprostone |
11.81 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
11.81 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.05 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.05 | 17333356 16919318 17110522 11677210 17681005 16105132 15861022 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 15340226 8697196 12621046 16354765 15668235 |
MESH:D003093 |
Colitis, Ulcerative |
|
Dinitrochlorobenzene |
3.89 | 17373747 19159591 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
2.70 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.70 | 20055451 15322242 10048152 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.90 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dinitrochlorobenzene |
8.11 | 15491423 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
8.11 | 11298694 16823706 16780908 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.40 | 17446233 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
4.58 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.58 | 17107852 |
MESH:D003967 |
Diarrhea |
|
Dinoprostone |
4.68 | 10446763 7237001 11488427 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.56 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004487 |
Edema |
|
rosiglitazone |
7.33 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.33 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.31 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.03 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.81 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.81 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
13.81 | 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005334 |
Fever |
|
Dinoprostone |
4.98 | 16997862 11852909 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.95 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.95 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.83 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.63 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.63 | 10048152 11294989 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.77 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.25 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 15340226 18606429 16959395 8697196 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Dinoprostone |
8.85 | 16793879 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
8.85 | 12083418 |
MESH:D006973 |
Hypertension |
|
Benzene |
8.83 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.83 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.83 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.88 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.88 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
5.35 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.35 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
3.87 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.79 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.22 | 10903974 8314463 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.22 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.82 | 12371664 |
MESH:D007938 |
Leukemia |
|
Benzene |
3.44 | 14694614 15935818 18335105 17119257 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
4.43 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
2.71 | 19478238 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dinoprostone |
3.79 | 15816358 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
3.79 | 15980055 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.79 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Dinoprostone |
3.48 | 15816358 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.61 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.61 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.61 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
6.23 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.23 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.24 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.98 | 14698565 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
6.73 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
6.73 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.73 | 20464547 18569708 6695378 18816296 20135361 20064080 17053015 20869020 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.73 | 16712894 15276417 17306315 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.73 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Benzene |
3.81 | 17584886 17119257 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
4.60 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
6.75 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
6.75 | 16827153 |
MESH:D008545 |
Melanoma |
|
Dinitrochlorobenzene |
3.86 | 12202904 17334785 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.86 | 16487513 19082730 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.47 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
MESH:D020326 |
Migraine without Aura |
|
Dinoprostone |
5.39 | 11304026 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.27 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
3.74 | 17119195 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
8.68 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.68 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.68 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.80 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
7.77 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.77 | 12854658 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
4.28 | 17479406 15935809 15576619 15913788 17178637 17119257 15727169 16737584 15612468 |
MESH:D010005 |
Osteoarthropathy, Secondary Hypertrophic |
|
Dinoprostone |
6.65 | 18500342 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
5.22 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.22 | 17306315 15276417 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
6.18 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.32 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11896295 11399792 11118676 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.16 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.16 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.68 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.68 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.68 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.88 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
2.60 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.60 | 2093021 20155912 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
5.11 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.18 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.18 | 17306315 16712894 16452187 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.87 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
10.00 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
10.00 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.58 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |